(DPRO) Draganfly - Overview
Stock: Drones, Robots, Controller, Software, Biometrics
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 171% |
| Relative Tail Risk | -17.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 96.25 |
| Character TTM | |
|---|---|
| Beta | 1.854 |
| Beta Downside | 1.110 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.02% |
| CAGR/Max DD | -0.45 |
Description: DPRO Draganfly December 23, 2025
Draganfly Inc. (NASDAQ:DPRO) designs, manufactures, and sells unmanned aerial systems (UAS) and related data-collection platforms across North America. Its product line spans quad-copters, fixed-wing drones, ground robots, handheld controllers, and proprietary software for live-streaming, mapping, and biometric telemetry, including a tele-health module that measures heart rate, SpO₂, and blood pressure. The firm also offers sanitary-spraying services for large venues and provides custom engineering, training, and GIS data services to public-safety, agriculture, industrial-inspection, and surveying customers.
As of FY 2023, Draganfly reported approximately $12.5 million in revenue and held $8 million in cash and short-term investments, giving it a liquidity runway of roughly 12 months at current burn rates. The global commercial drone market is projected to grow at a 15 % CAGR through 2029, driven by increased adoption in precision agriculture and infrastructure inspection-sectors where Draganfly’s LiDAR-enabled “Long-Range” and heavy-lift “Commander 3 XL” platforms have recent pilot deployments. A notable catalyst is the U.S. FAA’s ongoing rollout of Remote ID requirements, which could favor manufacturers that have already integrated compliant telemetry, a niche where Draganfly claims early compliance.
For a deeper, data-driven assessment of DPRO’s valuation dynamics, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -18.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.22 > 0.02 and ΔFCF/TA 88.47 > 1.0 |
| NWC/Revenue: 935.7% < 20% (prev 60.53%; Δ 875.1% < -1%) |
| CFO/TA -0.21 > 3% & CFO -16.4m > Net Income -18.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 11.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.6m) vs 12m ago 513.3% < -2% |
| Gross Margin: 19.53% > 18% (prev 0.19%; Δ 1933 % > 0.5%) |
| Asset Turnover: 17.36% > 50% (prev 68.76%; Δ -51.40% > 0%) |
| Interest Coverage Ratio: -13.91 > 6 (EBITDA TTM -16.5m / Interest Expense TTM 1.21m) |
Altman Z'' 6.77
| A: 0.90 (Total Current Assets 76.0m - Total Current Liabilities 6.44m) / Total Assets 77.1m |
| B: -1.70 (Retained Earnings -130.8m / Total Assets 77.1m) |
| C: -0.39 (EBIT TTM -16.9m / Avg Total Assets 42.8m) |
| D: 8.60 (Book Value of Equity 57.2m / Total Liabilities 6.65m) |
| Altman-Z'' Score: 6.77 = AAA |
Beneish M -3.31
| DSRI: 1.15 (Receivables 1.25m/854.2k, Revenue 7.43m/5.86m) |
| GMI: 0.99 (GM 19.53% / 19.40%) |
| AQI: 0.03 (AQ_t 0.00 / AQ_t-1 0.03) |
| SGI: 1.27 (Revenue 7.43m / 5.86m) |
| TATA: -0.02 (NI -18.1m - CFO -16.4m) / TA 77.1m) |
| Beneish M-Score: -3.31 (Cap -4..+1) = AA |
What is the price of DPRO shares?
Over the past week, the price has changed by +2.81%, over one month by -11.93%, over three months by -4.16% and over the past year by +114.14%.
Is DPRO a buy, sell or hold?
- StrongBuy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DPRO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.7 | 96.4% |
| Analysts Target Price | 14.7 | 96.4% |
| ValueRay Target Price | 5.8 | -22.8% |
DPRO Fundamental Data Overview February 04, 2026
P/S = 26.8653
P/B = 3.9745
Revenue TTM = 7.43m CAD
EBIT TTM = -16.9m CAD
EBITDA TTM = -16.5m CAD
Long Term Debt = 313.8k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 151.0k CAD (from shortTermDebt, last quarter)
Debt = 313.8k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -69.6m CAD (from netDebt column, last quarter)
Enterprise Value = 203.3m CAD (272.8m + Debt 313.8k - CCE 69.9m)
Interest Coverage Ratio = -13.91 (Ebit TTM -16.9m / Interest Expense TTM 1.21m)
EV/FCF = -12.04x (Enterprise Value 203.3m / FCF TTM -16.9m)
FCF Yield = -8.31% (FCF TTM -16.9m / Enterprise Value 203.3m)
FCF Margin = -227.2% (FCF TTM -16.9m / Revenue TTM 7.43m)
Net Margin = -243.3% (Net Income TTM -18.1m / Revenue TTM 7.43m)
Gross Margin = 19.53% ((Revenue TTM 7.43m - Cost of Revenue TTM 5.98m) / Revenue TTM)
Gross Margin QoQ = 19.52% (prev 23.85%)
Tobins Q-Ratio = 2.64 (Enterprise Value 203.3m / Total Assets 77.1m)
Interest Expense / Debt = 76.75% (Interest Expense 240.9k / Debt 313.8k)
Taxrate = 21.0% (US default 21%)
NOPAT = -13.3m (EBIT -16.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 11.80 (Total Current Assets 76.0m / Total Current Liabilities 6.44m)
Debt / Equity = 0.00 (Debt 313.8k / totalStockholderEquity, last quarter 70.4m)
Debt / EBITDA = 4.22 (negative EBITDA) (Net Debt -69.6m / EBITDA -16.5m)
Debt / FCF = 4.12 (negative FCF - burning cash) (Net Debt -69.6m / FCF TTM -16.9m)
Total Stockholder Equity = 24.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -42.24% (Net Income -18.1m / Total Assets 77.1m)
RoE = -72.67% (Net Income TTM -18.1m / Total Stockholder Equity 24.9m)
RoCE = -66.95% (EBIT -16.9m / Capital Employed (Equity 24.9m + L.T.Debt 313.8k))
RoIC = -53.56% (negative operating profit) (NOPAT -13.3m / Invested Capital 24.9m)
WACC = 12.74% (E(272.8m)/V(273.1m) * Re(12.75%) + (debt cost/tax rate unavailable))
Discount Rate = 12.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 229.5%
Fair Price DCF = unknown (Cash Flow -16.9m)
EPS Correlation: -70.11 | EPS CAGR: -18.11% | SUE: 0.01 | # QB: 0
Revenue Correlation: -1.33 | Revenue CAGR: 7.65% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.16 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=-0.58 | Chg30d=-0.009 | Revisions Net=+1 | Growth EPS=+56.4% | Growth Revenue=+144.4%